EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Breast cancer bone metastasis and bone metastatic cells retain NKG2DLs intracellularly: could this be a strategy to evade immune recognition?

Marta Gomarasca, Paola Maroni, Chiara Verdelli, Laura Gerosa, Martina Faraldi, Alessandro Luzzati, Luca Cannavò, Giuseppe Banfi, Giovanni Lombardi

Frontiers in Cell and Developmental Biology · 27.01.2026 · 14

DOI: 10.3389/fcell.2026.1717607 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 27.01.2026. Verfasst von Marta Gomarasca und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Experimental Biochemistry & Advanced Diagnostics, IRCCS Ospedale Galeazzi-Sant'Ambrogio, Milano, Italy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bone metastases dramatically worsen breast cancer (BC) prognosis reducing overall survival. Natural killer (NK) cells recognize and eliminate malignant cells through the interaction with NKG2D receptor ligands (NKG2DLs) on cancer cells. Tumors often evade NK surveillance by downregulating the NKG2DLs expression and avoid recognition, but whether this occurs in bone metastases remains unclear. This study investigates mechanisms of NKG2DLs downregulation in primary BC and bone metastases (BoMet). Expression and localization of the NKG2D/NKG2DL axis components were investigated in BC tissues (with and without metastases), paired bone metastatic ductal carcinoma (bmDC), BoMet, and in BC cells lines of varying invasiveness. In bmDC and BoMet, major histocompatibility complex class I chain-related protein A and B (MICA/B) and UL16-binding protein 2 (ULBP2) localized in perinuclear area, contrasting with predominantly cytosolic distribution in non-metastatic BC. Similarly, invasive MDA-MB-231 and MDA-BoM-1833 showed NKG2DLs perinuclear localization and co-localization with the Golgi apparatus, while less invasive MCF7 showed a prominent cytosolic distribution. Accumulation of NKG2DLs in membrane and cytoskeletal fractions further supports this pattern. Additionally, when N-glycosilation is impaired, NKG2DLs fail to reach the cell surface in metastatic cell lines, while are still transported through the Golgi apparatus and delivered to the plasma membrane, resulting in increased surface expression irrespective of correct glycosylation. Our findings suggest that invasive and bone-metastatic breast cancer cells are more dependent on correct glycosylation and intracellular trafficking for NKG2DL surface expression than non-metastatic breast cancer cells. This difference may have important implications for potential immune evasion mechanisms and for the development of therapeutic strategies targeting bone metastases in breast cancer.

Schlagwörter

Stichwörter der Autor:innen

NKNKG2DNKG2DLsbone metastasisbreast cancerbreast cancer immune evasion

Autor:innen und Institutionen

  • Laboratory of Experimental Biochemistry & Advanced Diagnostics, IRCCS Ospedale Galeazzi-Sant'Ambrogio, Milano, Italy.
  • Oncological and Reconstructive Surgery Unit, IRCCS Ospedale Galeazzi-Sant'Ambrogio, Milano, Italy.
  • Orthopedics and Traumatology Unit, Ospedale di Esine ASST Valcamonica, Esine, Italy.
  • Vita-Salute San Raffaele University, Milano, Italy.
  • Department of Athletics, Strength and Conditioning, Poznań University of Physical Education, Poznań, Poland.

Förderung

  • Ministero della Salute

Zitieren

APA

Gomarasca, M., Maroni, P., Verdelli, C., Gerosa, L., Faraldi, M., Luzzati, A., Cannavò, L., Banfi, G., & Lombardi, G. (2026). Breast cancer bone metastasis and bone metastatic cells retain NKG2DLs intracellularly: could this be a strategy to evade immune recognition?. Frontiers in Cell and Developmental Biology, 14. https://doi.org/10.3389/fcell.2026.1717607

Vancouver

Gomarasca M, Maroni P, Verdelli C, Gerosa L, Faraldi M, Luzzati A, et al. Breast cancer bone metastasis and bone metastatic cells retain NKG2DLs intracellularly: could this be a strategy to evade immune recognition?. Frontiers in Cell and Developmental Biology. 2026;14. doi:10.3389/fcell.2026.1717607

BibTeX
@article{Gomarasca2026,
  author = {Gomarasca, Marta and Maroni, Paola and Verdelli, Chiara and Gerosa, Laura and Faraldi, Martina and Luzzati, Alessandro and Cannavò, Luca and Banfi, Giuseppe and Lombardi, Giovanni},
  title = {Breast cancer bone metastasis and bone metastatic cells retain NKG2DLs intracellularly: could this be a strategy to evade immune recognition?},
  journal = {Frontiers in Cell and Developmental Biology},
  year = {2026},
  volume = {14},
  doi = {10.3389/fcell.2026.1717607}
}
Kostenlos starten →